Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Cancer Research
|
November 29, 2017
Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer
Jennifer Brooks, Bettina Fleischmann-Mundt, Norman Woller, et al.
Gynecologic Oncology
|
January 22, 2022
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
Yue Yin Xia, Jacek Gronwald, Beth Karlan, et al.
Journal of Medicinal Chemistry
|
April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase
Anne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Gastroenterology
|
May 24, 2016
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
Engin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, et al.
The Journal of Allergy and Clinical Immunology
|
July 6, 2024
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments
Lian-Sheng Li, Yuefen Zhou, Douglas E Murphy, et al.
Communications Medicine
|
April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada
Nareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
Journal of Medicinal Chemistry
|
October 1, 2004
Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication
Anne B Eldrup, Marija Prhavc, Jennifer Brooks, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
Frank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Cancer Research
|
November 29, 2017
Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer
Jennifer Brooks, Bettina Fleischmann-Mundt, Norman Woller, et al.
Gynecologic Oncology
|
January 22, 2022
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
Yue Yin Xia, Jacek Gronwald, Beth Karlan, et al.
Journal of Medicinal Chemistry
|
April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase
Anne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Gastroenterology
|
May 24, 2016
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
Engin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, et al.
The Journal of Allergy and Clinical Immunology
|
July 6, 2024
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments
Lian-Sheng Li, Yuefen Zhou, Douglas E Murphy, et al.
Communications Medicine
|
April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada
Nareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
Journal of Medicinal Chemistry
|
October 1, 2004
Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication
Anne B Eldrup, Marija Prhavc, Jennifer Brooks, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
Frank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Page
of 4